The NF TriSolve Sleep Health Solution Technology Forum is just 7 days away. Under the central theme "From Botanical Actives to Precision Delivery," the forum will systematically present Natural Field's technology upgrade roadmap and scientific exploration in sleep health, with a focus on the breakthrough advances in ashwagandha active innovation and co-loading liposome delivery technology.
01 Industry Insight: From "Help You Fall Asleep" to "Sleep Health Management"
Over the past decade, competition in the sleep market has centered on ingredients. Today, however, consumer demand is undergoing a profound shift — from simply "falling asleep" (Fall Asleep) to pursuing "sleep quality" (Sleep Quality). Sleep health management has emerged as the new industry keyword.
Data shows that sleep problems are widespread among modern populations: 47.44% report waking frequently at night, 49.36% experience frequent dreaming, and 44.87% struggle with difficulty falling asleep (Source: iiMedia Research, 2026). Issues such as difficulty falling asleep, nighttime waking, and early morning awakening have become invisible burdens affecting quality of life. What the market needs is no longer a single sleep aid ingredient, but a systematic solution capable of restoring circadian rhythm balance and complete physical and mental relaxation.
02 Core Innovation: Ashwagandha + Co-Loading Liposome Delivery
The forum will highlight Natural Field's sleep health innovation platform built around ashwagandha, as well as the breakthrough design of NF TriSolve's core delivery technology — co-loading liposomes.
Traditional liposomes are composed of phospholipids and cholesterol. NF TriSolve innovatively uses withanolides and their derivatives from ashwagandha as functional membrane materials, partially replacing cholesterol to form a new type of co-loading liposome based on "phospholipids + natural saponins." This technical improvement not only systematically enhances delivery efficiency but also opens up three major future exploration directions:
Nervous system regulation: exploring the functional regulatory potential of ashwagandha liposomes in the nervous system;
Brain delivery efficiency: investigating the impact of ashwagandha functional membrane materials on central nervous system delivery;
Gut-brain axis synergy: exploring the multi-system collaborative regulation of the nervous and gastrointestinal systems.
To date, ashwagandha liposomes have undergone multiple rounds of experiments, including in vitro cellular uptake, in vivo targeting validation, and tissue distribution studies, confirming excellent internalization efficiency and brain-targeted delivery capability.
03 Scientific Validation: Dual Evidence from Behavioral Phenotype to Molecular Signaling
NF TriSolve has established a comprehensive scientific validation system, using a zebrafish model for two-dimensional verification, confirming efficacy at both the behavioral and genetic levels:
Wakefulness activity reduced by 39%;
Total wakefulness duration shortened by 34%;
Three core genes simultaneously improved — gabra1 (GABA receptor alpha-1 subunit, the brain's "relaxation switch") upregulated by 52%; mtnr1aa (melatonin receptor MT1, the circadian "remote control") significantly upregulated; hcrt (orexin, the brain's "excitation alarm") significantly downregulated.
Behavioral improvement is the result; genetic improvement is the root cause. The NF TriSolve formula successfully achieves a three-pronged approach — promoting relaxation, strengthening circadian signals, and suppressing wakefulness impulses — delivering fundamental sleep restoration.
04 The Solution: Three-Layer Synergy, Multi-Pathway Intervention
The forum will also detail the scientific design philosophy of the NF TriSolve sleep improvement formula — a multi-dimensional sleep regulation system featuring three-layer synergy and multi-pathway intervention. A direct comparison with mainstream market products will demonstrate NF TriSolve's comprehensive advantages in delivery efficiency, mechanism of action, and efficacy performance.
This is the last one.
English
français
Deutsch
Español
русский
português
日本語